The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interplay between immune infiltration and tumor progression and survival in non-small cell lung cancer: An analysis of institutional and public data.
 
Ali Jalali
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Won-Chul Lee
No Relationships to Disclose
 
Jianhua Zhang
No Relationships to Disclose
 
Chia Chin Wu
No Relationships to Disclose
 
Don Lynn Gibbons
No Relationships to Disclose
 
XiMing Tang
No Relationships to Disclose
 
Neda Kalhor
No Relationships to Disclose
 
Julie Izzo
No Relationships to Disclose
 
Carmen Behrens
No Relationships to Disclose
 
Frank V. Fossella
No Relationships to Disclose
 
Anne S. Tsao
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Genentech/Roche; Imedex; Lilly; MedImmune; Novartis
Research Funding - Genentech/Roche (Inst); MedImmune (Inst); Merck (Inst); Millennium; Seagen
Travel, Accommodations, Expenses - Novartis
 
J. Jack Lee
No Relationships to Disclose
 
Stephen Swisher
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Andrew Futreal
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca; Asuragen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; GE Healthcare; Genecentric; Genentech/Roche; GlaxoSmithKline; HTG Molecular Diagnostics; Lilly; Lilly; Pfizer; Synta
Speakers' Bureau - Boehringer Ingelheim; Medscape; Pfizer
Research Funding - Bayer; Genentech; HTG Molecular Diagnostics; Jounce Therapeutics; Merck; Myriad Genetics; OncoPlex Diagnostics
 
Roy S. Herbst
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Lilly; Merck; Pfizer
Research Funding - Genentech; Merck
 
Vassiliki Papadimitrakopoulou
Consulting or Advisory Role - ARIAD; AstraZeneca; Biothera; Clovis Oncology; Genentech; Genentech; Gensignia Life Sciences; Janssen; Lilly; Merck
Research Funding - ACEA Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Jianjun Zhang
No Relationships to Disclose